Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Azuca is a drug delivery technology company that specializes in the rapid onset of bioactive compounds, with a primary focus on the cannabis and hemp industries. The company's core innovation is the TiME INFUSION (Thermodynamic Individual Molecular Encapsulation) platform, which makes lipophilic compounds like cannabinoids water-soluble. This technology allows active ingredients to bypass first-pass metabolism, resulting in a predictable onset of action within 2 to 15 minutes. Azuca operates as a B2B provider, licensing its proprietary formulations and manufacturing processes to consumer packaged goods brands. Their product suite includes specialized activators for gummies, beverages, and syrups, designed to improve the consumer experience through precision and efficiency. By addressing the bioavailability challenges of cannabinoids, Azuca is positioning its platform for broader applications in the pharmaceutical and nutraceutical sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Azuca.